Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

TBRIA (calcitonin-salmon) for the Treatment of Postmenopausal Osteoporosis

Drug (Brand / Generic)

TBRIA / calcitonin-salmon [rDNA origin] delayed release tablets

Company

Tarsa Therapeutics

Therapy Class

Salmon Calcitonin (r-DNA origin)

Current Indication

Postmenopausal osteoporosis

Market Sector

Musculoskeletal

Development Status

NDA under review by the US FDA
Expand

Go Top